This article is a retraction of:
RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
Frontiers Editorial Office*A Retraction of the Original Research Article
Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
by Zhang, Y. Y., Yang, Q. S., Qing, X., Li, B. R., Qian, J., Wang, Y., & Ning, B. T. (2020). Front. Oncol. 10:538779. doi: 10.3389/fonc.2020.538779
The Journal and Authors retract the 28 October 2020 article cited above for the following reasons provided by the Authors:
Following publication, concerns were raised regarding data misrepresentation. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Oncology and Chief Executive Editor. The authors agreed to this retraction.
Citation: Frontiers Editorial Office (2021) Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Front. Oncol. 11:709636. doi: 10.3389/fonc.2021.709636
Received: 14 May 2021; Accepted: 14 May 2021;
Published: 03 June 2021.
Approved by:
Rimas J. Orentas, Seattle Children’s Research Institute, United StatesCopyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org